Lipid- and polymer-based nanoparticle systems for the delivery of CRISPR/Cas9

被引：33

作者：

Ashok, Bhaargavi ^{[1
]}

Peppas, Nicholas A. ^{[1
,2
,3
,4
,5
]}

Wechsler, Marissa E. ^{[6
]}

机构：

[1] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA

[2] Univ Texas Austin, Inst Biomat Drug Delivery & Regenerat Med, Austin, TX 78712 USA

[3] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA

[4] Univ Texas Austin, Coll Pharm, Div Mol Pharmaceut & Drug Delivery, Austin, TX 78712 USA

[5] Univ Texas Austin, Dell Med Sch, Dept Surg & Perioperat Care, Austin, TX 78712 USA

[6] Univ Texas San Antonio, Dept Biomed Engn & Chem Engn, San Antonio, TX 78249 USA

来源：

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY | 2021年 / 65卷

基金：

美国国家卫生研究院;

关键词：

Hydrogels; Nanoparticles; CRISPR; Genome editing; IN-VIVO; TARGETED DELIVERY; MESSENGER-RNA; T-CELLS; GENE; CARRIERS; CANCER; VITRO; DNA; CRISPR-CAS9;

D O I：

10.1016/j.jddst.2021.102728

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The discovery of clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) genome editing systems and their applications in human health and medicine has heralded a new era of biotechnology. However, the delivery of CRISPR therapeutics is arguably the most difficult barrier to overcome for translation to in vivo clinical administration. Appropriate delivery methods are required to efficiently and selectively transport all gene editing components to specific target cells and tissues of interest, while minimizing off-target effects. To overcome this challenge, we discuss and critique nanoparticle delivery strategies, focusing on the use of lipid-based and polymeric-based matrices herein.

引用

页数：13

共 50 条

[11] Lipid and polymer mediated CRISPR/Cas9 gene editing
Gong, Yan
Tian, Siyu
Xuan, Yang
Zhang, Shubiao
JOURNAL OF MATERIALS CHEMISTRY B, 2020, 8 (20) : 4369 - 4386
[12] Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics
Brittany E. Givens
Youssef W. Naguib
Sean M. Geary
Eric J. Devor
Aliasger K. Salem
The AAPS Journal, 20
[13] Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics
Givens, Brittany E.
Naguib, Youssef W.
Geary, Sean M.
Devor, Eric J.
Salem, Aliasger K.
AAPS JOURNAL, 2018, 20 (06):
[14] Latest progress in the study of nanoparticle-based delivery of the CRISPR/Cas9 system
Yu, Mingyu
Liu, Xiaowen
Cheng, Hongbo
Kuang, Longhao
Zhang, Shaochong
Yan, Xiaohe
METHODS, 2021, 194 : 48 - 55
[15] Lipid- and Polymer-Based Nanocarrier Platforms for Cancer Vaccine Delivery
Sunoqrot, Suhair
Gaber, Sara A. Abdel
Abujaber, Razan
Al-Majawleh, May
Talhouni, Shahd
ACS APPLIED BIO MATERIALS, 2024, 7 (08) : 4998 - 5019
[16] Liposomal delivery of CRISPR/Cas9
Zhen, Shuai
Li, Xu
CANCER GENE THERAPY, 2020, 27 (7-8) : 515 - 527
[17] Nanoparticles for CRISPR–Cas9 delivery
Zachary Glass
Yamin Li
Qiaobing Xu
Nature Biomedical Engineering, 2017, 1 : 854 - 855
[18] Application of nanoparticle-based siRNA and CRISPR/Cas9 delivery systems in gene-targeted therapy
Tao, Yingkai
Hou, Xiaoyang
Zuo, Fengmei
Li, Xinxin
Pang, Yanyu
Jiang, Guan
NANOMEDICINE, 2019, 14 (05) : 511 - 514
[19] Liposomal delivery of CRISPR/Cas9
Shuai Zhen
Xu Li
Cancer Gene Therapy, 2020, 27 : 515 - 527
[20] Lipid-based nanocarrier mediated CRISPR/Cas9 delivery for cancer therapy
Aziz, Aisha
Rehman, Urushi
Sheikh, Afsana
Abourehab, Mohammed A. S.
Kesharwani, Prashant
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2023, 34 (03) : 398 - 418

← 1 2 3 4 5 →